Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01816958 · ClinicalTrials.gov registry record
Neuromodulation to Facilitate the Effect of Ketamine
A clinical trial of Depression and Chronic Pain, sponsored by The Neuroscience Center.
- Completed
- Registry status
- 35
- Enrollment target
- 1
- Study location
NCT01816958 is a study of Depression and Chronic Pain that has completed, run by The Neuroscience Center. The registered enrollment target is 35 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01816958, a study of Depression and Chronic Pain, has completed, sponsored by The Neuroscience Center.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
application of external neuromodulation along with ketamine infusion.
Conditions Studied
Interventions
- OTHER co-administration of TMS and infused ketamine
Study Locations (1)
Illinois
- The Neuroscience Center - Deerfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01816958
The ClinicalTrials.gov registry entry for NCT01816958 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower). The listed sponsor is The Neuroscience Center, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which co-administration of TMS and infused ketamine is the first listed.
NCT01816958 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01816958 about?
NCT01816958 is a clinical study titled "Neuromodulation to Facilitate the Effect of Ketamine". application of external neuromodulation along with ketamine infusion.
What is the current status of trial NCT01816958?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2011-01. Estimated completion is 2012-11.
What conditions does trial NCT01816958 study?
This clinical trial studies the following conditions: Depression, Chronic Pain, Substance Abuse.
What interventions are being tested in trial NCT01816958?
The interventions under investigation include: co-administration of TMS and infused ketamine (OTHER).
Who is sponsoring clinical trial NCT01816958?
This trial is sponsored by The Neuroscience Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01816958 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.